{
    "organizations": [],
    "uuid": "bbf092a927d607f8bd536f6d2570eb55336a7035",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ucb-acquires-element-genomics/brief-ucb-acquires-element-genomics-idUSFWN1RH0OB",
    "ord_in_thread": 0,
    "title": "BRIEF-UCB Acquires Element Genomics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - UCB SA:\n* UCB STRENGTHENS RESEARCH CAPABILITIES WITH ACQUISITION OF ELEMENT GENOMICS, A DUKE UNIVERSITY BIOTECH SPIN-OFF\n* ‍TOTAL COST OF TRANSACTION WILL AMOUNT TO UP TO USD 30 MILLION​\n* ‍ELEMENT GENOMICS’ TEAM WILL CONTINUE TO BE BASED IN DOWNTOWN DURHAM, WILL WORK CLOSELY WITH UCB’S RESEARCH TEAMS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T13:07:00.000+03:00",
    "crawled": "2018-04-06T22:03:33.022+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ucb",
        "sa",
        "ucb",
        "strengthens",
        "research",
        "capability",
        "acquisition",
        "element",
        "genomics",
        "duke",
        "university",
        "biotech",
        "cost",
        "transaction",
        "amount",
        "usd",
        "genomics",
        "team",
        "continue",
        "based",
        "downtown",
        "durham",
        "work",
        "closely",
        "ucb",
        "research",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}